MB-CART2019.1
- Generic Name
- MB-CART2019.1
US Zamto-cel Autoimmune Diseases
Phase 1
Not yet recruiting
- Conditions
- Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)Diffuse Cutaneous Systemic Sclerosis
- Interventions
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT06708845
MB-dNPM1-TCR.1 in Relapsed/refractory AML
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 29
- Registration Number
- NCT06424340
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath